These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21301936)

  • 21. Prediction of optimal warfarin maintenance dose using advanced artificial neural networks.
    Grossi E; Podda GM; Pugliano M; Gabba S; Verri A; Carpani G; Buscema M; Casazza G; Cattaneo M
    Pharmacogenomics; 2014 Jan; 15(1):29-37. PubMed ID: 24329188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials.
    Ravvaz K; Weissert JA; Ruff CT; Chi CL; Tonellato PJ
    Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.
    Svec JM; Coleman RW; Mungall DR; Ludden TM
    Ther Drug Monit; 1985; 7(2):174-80. PubMed ID: 4024210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benchmarking therapeutic drug monitoring software: a review of available computer tools.
    Fuchs A; Csajka C; Thoma Y; Buclin T; Widmer N
    Clin Pharmacokinet; 2013 Jan; 52(1):9-22. PubMed ID: 23196713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of Akaike information criterion to evaluate warfarin dosing algorithm.
    Harada T; Ariyoshi N; Shimura H; Sato Y; Yokoyama I; Takahashi K; Yamagata S; Imamaki M; Kobayashi Y; Ishii I; Miyazaki M; Kitada M
    Thromb Res; 2010 Sep; 126(3):183-90. PubMed ID: 20553802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulation.
    Salinger DH; Shen DD; Thummel K; Wittkowsky AK; Vicini P; Veenstra DL
    Pharmacogenet Genomics; 2009 Dec; 19(12):965-71. PubMed ID: 19881396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic analysis and comparison of warfarin initiation strategies.
    French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
    Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal loading dose for the initiation of warfarin: a systematic review.
    Heneghan C; Tyndel S; Bankhead C; Wan Y; Keeling D; Perera R; Ward A
    BMC Cardiovasc Disord; 2010 Apr; 10():18. PubMed ID: 20403189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables.
    Sagreiya H; Altman RB
    J Biomed Inform; 2010 Oct; 43(5):747-51. PubMed ID: 20363365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A.
    Delavenne X; Dargaud Y; Ollier E; Négrier C
    Br J Clin Pharmacol; 2019 Apr; 85(4):771-781. PubMed ID: 30633808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.
    Zhang J; Tian L; Huang J; Huang S; Chai T; Shen J
    Cardiovasc Ther; 2017 Feb; 35(1):26-32. PubMed ID: 27661060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic.
    Shoji M; Suzuki S; Otsuka T; Arita T; Yagi N; Semba H; Kano H; Matsuno S; Kato Y; Uejima T; Oikawa Y; Matsuhama M; Yajima J; Yamashita T
    Intern Med; 2020 Jan; 59(1):29-35. PubMed ID: 31511484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
    Hennig S; Norris R; Kirkpatrick CM
    Br J Clin Pharmacol; 2008 Apr; 65(4):502-10. PubMed ID: 17995972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
    Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
    J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients.
    Xue L; Holford N; Ding XL; Shen ZY; Huang CR; Zhang H; Zhang JJ; Guo ZN; Xie C; Zhou L; Chen ZY; Liu LS; Miao LY
    Br J Clin Pharmacol; 2017 Apr; 83(4):823-835. PubMed ID: 27763679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of anticoagulant therapy applying a dynamic statistical model.
    Nielsen PB; Lundbye-Christensen S; Larsen TB; Kristensen SR; Hejlesen OK
    Comput Methods Programs Biomed; 2013 Jun; 110(3):380-8. PubMed ID: 23305998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal individualized dosing strategies: A pharmacologic approach to developing dynamic treatment regimens for continuous-valued treatments.
    Rich B; Moodie EE; Stephens DA
    Biom J; 2016 May; 58(3):502-17. PubMed ID: 26537297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimising the dose of oral anticoagulants.
    Shetty HG; Routledge PA
    Ann Acad Med Singap; 1991 Jan; 20(1):161-4. PubMed ID: 2029156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII.
    Abrantes JA; Solms A; Garmann D; Nielsen EI; Jönsson S; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2019 Dec; 8(12):894-903. PubMed ID: 31668021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.